Chu, T., & Du, W. (2015). Can determination of circulating endothelial cells and serum caspase-cleaved CK18 Predict for response and survival in patients with advanced non-small-cell lung cancer receiving endostatin and paclitaxel-carboplatin chemotherapy?: A retrospective study. Journal of thoracic oncology, 7(12), . https://doi.org/10.1097/JTO.0b013e3182725fe0
Chicago-Zitierstil (17. Ausg.)Chu, Tian-Qing, und Wei-Dong Du. "Can Determination of Circulating Endothelial Cells and Serum Caspase-cleaved CK18 Predict for Response and Survival in Patients with Advanced Non-small-cell Lung Cancer Receiving Endostatin and Paclitaxel-carboplatin Chemotherapy?: A Retrospective Study." Journal of Thoracic Oncology 7, no. 12 (2015). https://doi.org/10.1097/JTO.0b013e3182725fe0.
MLA-Zitierstil (9. Ausg.)Chu, Tian-Qing, und Wei-Dong Du. "Can Determination of Circulating Endothelial Cells and Serum Caspase-cleaved CK18 Predict for Response and Survival in Patients with Advanced Non-small-cell Lung Cancer Receiving Endostatin and Paclitaxel-carboplatin Chemotherapy?: A Retrospective Study." Journal of Thoracic Oncology, vol. 7, no. 12, 2015, https://doi.org/10.1097/JTO.0b013e3182725fe0.